1) Continuing our work on exosomes as a source of biomarkers, we found that transcription factors ATF3 and WT-1 were capable of detecting acute kidney injury and chronic kidney disease, respectively, in animal models and a few patients. We continue refinement of these promising biomarker candidates in larger sets of patients, as well as in animal models.? ? 2) We have shifted our MRI imaging efforts from gadolinium-based contrast agents, whose potential for toxicity impedes further development, to less toxic agents. We were used a novel contrast agent, cationized ferritin, designed to be retained by the glomerular basement membrane, as a contrast agent to detect glomeruli. By MRI with cationized ferritin normal rats could be distinguished from rats with focal segmental glomerulosclerosis, where the glomerular basement membrane is disrupted.
Showing the most recent 10 out of 35 publications